This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Dentsply (XRAY) Up 1% Since Last Earnings Report?
by Zacks Equity Research
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
4 S&P 500 Stocks Up More Than 30% YTD With More Room to Run
by Madhurima Das
Despite the S&P 500 incurring a 15.7% YTD loss owing to inflation and high interest rates, stocks like ENPH, HAL, CAH and WRB have soared. They are poised to maintain the momentum in 2023.
Is Acer Therapeutics (ACER) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Acer Therapeutics Inc. (ACER) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPYD
Zacks Investment Ideas feature highlights: McKesson, Cardinal Health and Super Micro Computer
by Zacks Equity Research
McKesson, Cardinal Health and Super Micro Computer are part of the Zacks Investment Ideas article.
3 Stocks Silently Outperforming Energy in 2022
by Derek Lewis
Outperforming the Zacks Oils and Energy sector in 2022 is no easy task. However, bulls have silently roamed in all three of these stocks, breaking the overall bearish trend we've become accustomed to.
Is WisdomTree U.S. MidCap Dividend ETF (DON) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DON
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
by Zacks Equity Research
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.
Cardinal Health's (CAH) Velocare to Enhance at-Home Care
by Zacks Equity Research
Cardinal Health's (CAH) latest launch is expected to significantly expand its at-Home Solutions supply chain and logistics services, thereby improving patient care.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
by Zacks Equity Research
Sector ETF report for RYH
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYH
Company News for Nov 7, 2022
by Zacks Equity Research
Companies In The News Are: ENB, CAH, WPC, EVRG.
Should WisdomTree U.S. MidCap Dividend ETF (DON) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DON
Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cardinal Health's (CAH) fiscal first-quarter results benefit from the solid performance of the Pharmaceutical segment.
Cardinal Health (CAH) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cardinal (CAH) delivered earnings and revenue surprises of 25% and 5.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Staar Surgical (STAA) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Staar Surgical (STAA) delivered earnings and revenue surprises of 76.19% and 1.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DEF
Cardinal Health (CAH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Cardinal Health (CAH) closed at $75.90, marking a -1.61% move from the previous day.
Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Cardinal Health's (CAH) first-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have continued.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
Analysts Estimate Cardinal Health (CAH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardinal Health (CAH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Cardinal Health (CAH) closed the most recent trading day at $73.72, moving -0.11% from the previous trading session.
Zacks.com featured highlights include American Airlines, Delta Air Lines, CVR Energy, Bunge Ltd. and Cardinal Health
by Zacks Equity Research
American Airlines, Delta Air Lines, CVR Energy, Bunge Ltd. and Cardinal Health are part of Zacks Screen of the Week article.
Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDIV
Check 5 Broker-Friendly Stocks for Returns Amid Market Chaos
by Maharathi Basu
Broker-favorite stocks like American Airlines (AAL), Delta (DAL), CVR Energy (CVI), Bunge Limited (BG) and Cardinal Health (CAH) should be on an investor's watch list.